Semaglutide in medical therapy including weight management
TW202641825APending Publication Date: 2026-10-16NOVO NORDISK AS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101579
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-13
- Filing Date
- 2026-01-15
- Publication Date
- 2026-10-16
Abstract
This invention provides a GLP-1 receptor agonist, semaglutide, for use in pharmaceutical therapies including weight management. The present disclosure provides a GLP-1 receptor agonist semaglutide for use in medical therapy including weight management.
Need to check novelty before this filing date? Find Prior Art